Clinical Update: Cholera Vaccine for Travelers

Join us for our first COCA Call with interactive polling!
Use of computer or smartphone is highly encouraged for polling portion.
(Interactive polling requires downloading free Zoom App if participating via smartphone.
Zoom Mobile Apps are available hereExternal.)

Image of Continuing Education Credits abbreviation. = Free Continuing Education

Date: Thursday, February 7, 2019

Time: 2:00pm-3:00pm (Eastern Time)

Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WC2922-0207919 – (Webcast) Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COCA Call–Clinical Update: Cholera Vaccine for Travelers – February 7, 2019, please visit TCEO and follow these 9 Simple Steps by March 11, 2019.

To receive continuing education (CE) for WD2922-0207919 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COCA Call–Clinical Update: Cholera Vaccine for Travelers – February 7, 2019  (Web on Demand), please visit TCEO and follow these 9 Simple Steps by March 12, 2021.

Overview

Cholera is a disease spread by drinking water or eating food contaminated with toxigenic Vibrio cholerae bacteria. Severe cholera is characterized by large amounts of watery diarrhea, often described as “rice-water stool” because it can have a pale, milky appearance. It can also be accompanied by nausea and vomiting. If untreated, the loss of fluid can be deadly. But simple treatment, including replacing lost body fluids, can lower mortality to less than 1%. From 2010 through 2014, 91 cases of cholera were confirmed in the United States among people who had traveled internationally in the week before illness onset. Of these, 75% were associated with travel to the Caribbean, and 10% were associated with travel to India or Pakistan. Cholera can be prevented by heeding food and water precautions and receiving cholera vaccine before travel.

During this COCA Call, CDC travel medicine subject matter expert and infectious diseases physician Dr. Kristina Angelo and food and water expert Dr. Erin Conners will

  • Highlight critical information about cholera biology and prevention;
  • Discuss strategies primary care providers and medical subspecialists can use to decrease the likelihood of cholera illness in their patients; and
  • Review CDC resources on the epidemiology of cholera vaccine to use in clinical decision making about offering vaccine to patients.

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Activity Specific Objectives
At the conclusion of the session, the participant will be able to accomplish the following:

  • Describe cholera as an infectious agent.
  • Identify key transmission routes of cholera.
  • List recommendations for prevention strategies for cholera.
  • Discuss cholera vaccine recommendations and CDC resources for cholera vaccine.

Call Slides: View NowCdc-pdf
Webinar: Watch NowCdc-media

Kristina M. Angelo, DO, MPH&TM
Medical Epidemiologist
Travelers’ Health Branch
Division of Global Migration and Quarantine
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Erin Conners, PhD, MPH
Epidemic Intelligence Officer
Waterborne Disease Prevention Branch
Division of Foodborne, Waterborne, and Environmental Diseases
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Join us for our first COCA Call with interactive polling!
Use of computer or smartphone is highly encouraged for polling portion.
(Interactive polling requires downloading free Zoom App if participating via smartphone.
Zoom Mobile Apps are available hereExternal.)

  • Webinar/Audio conference call on Thursday, February 7, 2019, 2019: 2:00 – 3:00 PM ET
  • Web-on-demand training will be available a few days after the live call.

To access the webinar:
A few minutes before the webinar begins

When: February 7, 2019 2:00 PM Eastern Time (US and Canada)
Topic: COCA Call: Clinical Update: Cholera Vaccine for Travelers

Please click the link below to join the webinar:
https://zoom.us/j/883825945External

Or iPhone one-tap:
US: +16468769923,,883825945# or +16699006833,,883825945#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 646 876 9923 or +1 669 900 6833
Webinar ID: 883 825 945
International numbers available: https://zoom.us/u/abM1dOdLqMExternal

WC2922   0387-0000-19-057-L04-P (must be completed by March 11, 2019)
WD2922   0387-0000-19-057-H04-P (must be completed by March 12, 2021)

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians
  • Contact Information:coca@cdc.gov
  • Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation:You may participate in the educational activity by viewing the program information above.
  • Fees: COCA Continuing Education (CE) is free.

Accreditation Statements

CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

Image of acpe logo.CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-19-057-L04-P  and enduring 0387-0000-19-057-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)

The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.

AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

Page last reviewed: January 24, 2019